Market Place
Sourcing Support
Praxis Precision Medicines Gets FDA Breakthrough Status
29 Dec 2025 //
GLOBENEWSWIRE
FDA Clears Ulixacaltamide Pre-NDA for Essential Tremor
04 Dec 2025 //
GLOBENEWSWIRE
Praxis Precision Medicines to Participate in Fireside Chat
20 Nov 2025 //
GLOBENEWSWIRE
Praxis Precision Medicines Reports Positive Phase 3 Results
16 Oct 2025 //
GLOBENEWSWIRE
Praxis Precision Medicines Reports Q2 2024 Results And Corporate Update
13 Aug 2024 //
GLOBENEWSWIRE
Praxis At AAN On Ulixacaltamide
12 Apr 2024 //
GLOBENEWSWIRE
Praxis Precision Announces Collaboration Agreement with Tenacia
05 Jan 2024 //
GLOBENEWSWIRE
Praxis Precision Medicines Announces Positive Data from Study for Ulixacaltamide
08 Aug 2023 //
GLOBENEWSWIRE
Praxis Announces Plans to Begin Ulixacaltamide Phase 3 in Essential Tremor
09 Jun 2023 //
GLOBENEWSWIRE
Praxis Precision Medicines Announces Upcoming Ulixacaltamide
17 Apr 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.